Suchergebnisse - "Treilleux, Isabelle"

PubPharm (286)

71

Molecular Characterization of Ovarian Yolk Sac Tumor (OYST)

enthalten in: Cancers | 2021

von Hodroj, K. | Stevovic, A. | Attignon, V. | +13

72

Combined proteomic and transcriptomic approaches reveal externalized keratin 8 as a potential therapeutic target involved in invasiveness of head and neck cancers

enthalten in: Translational oncology | 2021

von Albaret, M. | Paré, A. | Malet, L. | +13

73

Publisher Correction : Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

enthalten in: Scientific reports | 2020

von De Talhouet, S. | Peron, J. | Vuilleumier, A. | +14

ErratumFor: Sci Rep. 2020 Apr 27;10(1):7073. - PMID 32341426

74

Nice-Saint-Paul de Vence 2020 recommendations for clinical practice : Management of metastatic and/or relapsing endometrial cancer

enthalten in: Bulletin du cancer | 2020

von Alexandre, J. | Le Frere-Belda, M. | Prulhiere, K. | +7

75

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural History

enthalten in: Cancers | 2020

von Brahmi, M. | Franceschi, T. | Treilleux, I. | +12

76

Analysis of genomic and non-genomic signalling of oestrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor Alpelisib (BYL719) and fulvestrant

enthalten in: ResearchSquare.com | 2020

von Romancer, M. | Jacquemetton, J. | Kassem, L. | +13

77

ERα-36 regulates progesterone receptor activity in breast cancer

enthalten in: Breast cancer research : BCR | 2020

von Konan, H. | Kassem, L. | Omarjee, S. | +8

78

ERα-36 regulates progesterone receptor activity in breast cancer

enthalten in: Breast cancer research | 2020

von Konan, H. | Kassem, L. | Omarjee, S. | +8

79

ERα-36 regulates progesterone receptor activity in breast cancer

enthalten in: Breast cancer research | 2020

von Konan, H. | Kassem, L. | Omarjee, S. | +8

80

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

enthalten in: Scientific reports | 2020

von De Talhouet, S. | Peron, J. | Vuilleumier, A. | +14

ErratumIn: Sci Rep. 2020 Nov 2;10(1):19248. - PMID 33139817